• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION CAPIOX RX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION CAPIOX RX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/27/2023
Event Type  Injury  
Event Description
The user facility reported poor oxygenation.It was replaced with a new rx05; however, the oxygenation did not improve.The event occurred intra-operative.There was no patient injury or medical/surgical intervention required.There was no health hazard attributable to the event.The procedure outcome was not reported.The final patient impact was not harmed.
 
Manufacturer Narrative
A1: patient identifier: requested, not provided a2: age & date of birth: requested, not provided a4: weight: requested, not provided a5: ethnicity: requested, not provided a6: race: requested, not provided d6a: implanted date: device was not implanted d6b: explanted date: device was not explanted e1: establishment name: unknown e3: occupation: clinical engineer visual inspection of the actual sample upon receipt found no anomaly such as a breakage.The actual sample, after rinsed and dried, was tested for the o2 transfer and co2 removal performance in accordance with the product inspection protocol.It was confirmed to meet the factory's specifications.No anomaly was found.[bovine blood conditions] hb: 12 g/dl, temp.: 37°c., ph: 7.4, svo2: 65%, pvco2: 45 mmhg [circulation conditions] blood flow rate: 2 l/min and 1 l/min, v/q:1, fio2: 100% [o2 transfer volume] @2l/min: 116 ml/min., @1l/min: 65 ml/min [co2 removal volume] @2l/min: 99 ml/min., @1l/min: 57 ml/min review of the manufacturing record and the shipping inspection record of the actual sample found no anomaly.Search of the past complaint file of the involved product code/lot# found no other similar report was found.Based on the investigation result, the gas transfer performance of the actual sample after cleaning met the factory's specifications, and no anomaly was found.Since no anomaly was found in the actual sample, the cause of occurrence could not be clarified.Relevant instructions for use (ifu) reference: "start gas supply with v/q=1, and fio2=100%, then make adjustments based on blood gas measurements." "measure blood gases and make necessary adjustments as follows.A.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.-to decrease pao2, decrease fio2.-to increase pao2, increase fio2.B.Control paco2 by changing the total gas flow.-to decrease paco2, increase total gas flow.-to increase paco2, decrease total gas flow." "a phenomenon called wet lung may occur when water condensation occurs inside fibers of microporous membrane oxygenators with blood flowing exterior to the fibers.This may occur when oxygenators are used for a longer period of time.If water condensation and/or a decrease in pao2 and/or an increase in paco2 is noted during extended oxygenator use, briefly increasing the gas flow rate may improve the performance.Increase gas flow rate, to 5 l/min for 10 seconds.Do not repeat this flushing technique, even if oxygenator performance is not improved." terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX RX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
4103927218
MDR Report Key18193346
MDR Text Key328817635
Report Number9681834-2023-00227
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350763471
UDI-Public04987350763471
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K040210
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Nurse Practitioner
Type of Report Initial
Report Date 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberN/A
Device Catalogue NumberCX*RX05RW
Device Lot Number230421
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/06/2023
Date Manufacturer Received10/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexMale
-
-